All Title Author
Keywords Abstract


Smad3 Deficiency Ameliorates Hepatic Fibrogenesis through the Expression of Senescence Marker Protein-30, an Antioxidant-Related Protein

DOI: 10.3390/ijms141223700

Keywords: liver fibrosis, Smad3, SMP-30, antioxidant

Full-Text   Cite this paper   Add to My Lib

Abstract:

Smad3 is a key mediator of the transforming growth factor (TGF)-β1 signaling pathway that plays central role in inflammation and fibrosis. In present study, we evaluated the effect of Smad3 deficiency in Smad3?/? mice with carbon tetrachloride (CCl 4)-induced liver fibrosis. The animals were received CCl 4 or olive oil three times a week for 4 weeks. Histopathological analyses were performed to evaluate the fibrosis development in the mice. Alteration of protein expression controlled by Smad3 was examined using a proteomic analysis. CCl 4-induced liver fibrosis was rarely detected in Smad3?/? mice compared to Smad3+/+. Proteomic analysis revealed that proteins related to antioxidant activities such as senescence marker protein-30 ( SMP30), selenium-binding proteins (SP56) and glutathione S-transferases (GSTs) were up-regulated in Smad3?/? mice. Western blot analysis confirmed that SMP30 protein expression was increased in Smad3?/? mice. And SMP30 levels were decreased in CCl 4-treated Smad3 + / + and Smad3?/? mice. These results indicate that Smad3 deficiency influences the proteins level related to antioxidant activities during early liver fibrosis. Thus, we suggest that Smad3 deteriorate hepatic injury by inhibitor of antioxidant proteins as well as mediator of TGF-β1 signaling.

References

[1]  Biernacka, A.; Dobaczewski, M.; Frangogiannis, N.G. TGF-β signaling in fibrosis. Growth Factors 2011, 29, 196–202.
[2]  Dooley, S.; Ten Dijke, P. TGF-β in progression of liver disease. Cell Tissue Res 2012, 347, 245–256.
[3]  Han, G.; Wang, X.J. Roles of TGFβ signaling Smads in squamous cell carcinoma. Cell Biosci 2011, 28, 1–41.
[4]  Matsuzaki, K. Smad phosphoisoform signals in acute and chronic liver injury: Similarities and differences between epithelial and mesenchymal cells. Cell Tissue Res 2012, 347, 225–243.
[5]  Stramer, B.M.; Austin, J.S.; Roberts, A.B.; Fini, M.E. Selective reduction of fibrotic markers in repairing corneas of mice deficient in Smad3. J. Cell Physiol 2005, 203, 226–232.
[6]  Megiorni, F.; Cialfi, S.; Cimino, G.; de Biase, R.V.; Dominici, C.; Quattrucci, S.; Pizzuti, A. Elevated levels of miR-145 correlate with Smad3 down-regulation in Cystic Fibrosis patients. J. Cyst. Fibros 2013, doi:10.1016/j.jcf.2013.03.007.
[7]  Hu, B.; Wu, Z.; Phan, S.H. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am. J. Resp. Cell Mol. Biol 2003, 29, 397–404.
[8]  Flanders, K.C.; Major, C.D.; Arabshahi, A.; Aburime, E.E.; Okada, M.H.; Fujii, M.; Blalock, T.D.; Schultz, G.S.; Sowers, A.; Anzano, M.A.; et al. Interference with transforming growth factor-beta/Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. Am. J. Pathol 2003, 163, 2247–2257.
[9]  Liu, Z.; Huang, X.R.; Lan, H.Y. Smad3 mediates ANG II-induced hypertensive kidney disease in mice. Am. J. Physiol. Renal Physiol 2012, 302, F986.
[10]  Low, T.Y.; Leow, C.K.; Salto-Tellez, M.; Chung, M.C. A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers. Proteomics 2004, 4, 3960–3974.
[11]  Mendler, M.H.; Kanel, G.; Govindarajan, S. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease. Liver Int 2005, 25, 294–304.
[12]  Haschek, W.M.; Rousseaux, C.G. Handbook of Toxicologic Pathology, 2nd ed ed.; Academic Press: San Francisco, CA, USA, 2002; pp. 72–75.
[13]  Fujita, T.; Uchida, K.; Maruyama, N. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim. Biophys. Acta 1992, 1116, 122–128.
[14]  Kondo, Y.; Inai, Y.; Sato, Y.; Handa, S.; Kubo, S.; Shimokado, K.; Goto, S.; Nishikimi, M.; Maruyama, N.; Ishigami, A. Senescence marker protein 30 functions as gluconolactonase in l-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc. Natl. Acad. Sci. USA 2006, 103, 5723–5728.
[15]  Son, T.G.; Zou, Y.; Jung, K.J.; Yu, B.P.; Ishigami, A.; Maruyama, N.; Lee, J. SMP30 deficiency causes increased oxidative stress in brain. Mech. Ageing Dev 2006, 127, 451–457.
[16]  Andreyev, A.Y.; Kushnareva, Y.E.; Starkov, A.A. Mitochondrial metabolism of reactive oxygen species. Biochemistry 2005, 70, 200–214.
[17]  Yang, X.; Letterio, J.J.; Lechleider, R.J.; Chen, L.; Hayman, R.; Gu, H.; Roberts, A.B.; Deng, C. Targeted disruption of Smad3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J 1999, 18, 1280–1291.
[18]  Ishigami, A.; Fujita, T.; Handa, S.; Shirasawa, T.; Koseki, H.; Kitamura, T.; Enomoto, N.; Sato, N.; Shimosawa, T.; Maruyama, N. Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha- and Fas-mediated apoptosis. Am. J. Pathol 2002, 161, 1273–1281.
[19]  Fountoulakis, M.; de Vera, M.C.; Crameri, F.; Boess, F.; Gasser, R.; Albertini, S.; Suter, L. Modulation of gene and protein expression by carbon tetrachloride in the rat liver. Toxicol. Appl. Pharmacol 2002, 183, 71–80.
[20]  Gorg, A.; Obermaier, C.; Boguth, G.; Harder, A.; Scheibe, B.; Wildgruber, R.; Weiss, W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000, 21, 1037–1053.

Full-Text

comments powered by Disqus